Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.

Breast Cancer Res Treat 2018 01 9;167(1):289-301. Epub 2017 Sep 9.

Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.

Purpose: Cell lines are extremely useful tools in breast cancer research. Their key benefits include a high degree of control over experimental variables and reproducibility. However, the advantages must be balanced against the limitations of modelling such a complex disease in vitro. Informed selection of cell line(s) for a given experiment now requires essential knowledge about molecular and phenotypic context in the culture dish.

Methods: We performed multidimensional profiling of 36 widely used breast cancer cell lines that were cultured under standardised conditions. Flow cytometry and digital immunohistochemistry were used to compare the expression of 14 classical breast cancer biomarkers related to intrinsic molecular profiles and differentiation states: EpCAM, CD24, CD49f, CD44, ER, AR, HER2, EGFR, E-cadherin, p53, vimentin, and cytokeratins 5, 8/18 and 19.

Results: This cell-by-cell analysis revealed striking heterogeneity within cultures of individual lines that would be otherwise obscured by analysing cell homogenates, particularly amongst the triple-negative lines. High levels of p53 protein, but not RNA, were associated with somatic mutations (p = 0.008). We also identified new subgroups using the nanoString PanCancer Pathways panel (730 transcripts representing 13 canonical cancer pathways). Unsupervised clustering identified five groups: luminal/HER2, immortalised ('normal'), claudin-low and two basal clusters, distinguished mostly by baseline expression of TGF-beta and PI3-kinase pathway genes.

Conclusion: These features are compared with other published genotype and phenotype information in a user-friendly reference table to help guide selection of the most appropriate models for in vitro and in vivo studies, and as a framework for classifying new patient-derived cancer cell lines and xenografts.

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4496-x
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4496-xDOI Listing
January 2018
35 Reads

Publication Analysis

Top Keywords

cell lines
20
breast cancer
16
cancer cell
12
lines
7
cell
6
cancer
6
distinguished baseline
4
cd49f cd44
4
cd44 her2
4
baseline expression
4
her2 egfr
4
states epcam
4
expression tgf-beta
4
clusters distinguished
4
epcam cd24
4
cd24 cd49f
4
basal clusters
4
8/18 19results
4
claudin-low basal
4
19results cell-by-cell
4

References

(Supplied by CrossRef)

A Hollestelle et al.
Breast Cancer Res Treat 2009

PJ Keller et al.
Breast cancer research: BCR 2010

BD Lehmann et al.
J Clin Invest 2011

RM Neve et al.
Cancer Cell 2006

A Prat et al.
Breast cancer research: BCR 2010

CE Smart et al.
PLoS ONE 2013

J Kao et al.
PLoS ONE 2009

A Daemen et al.
Genome Biol 2013

J Barretina et al.
Nature 2012

BD Lehmann et al.
PLoS ONE 2016

CM Fillmore et al.
Breast Cancer Res 2008

Similar Publications